NeuroOne Medical Technologies Corporation (NASDAQ: NMTC)

NeuroOne Medical Technologies Corporation, based in Eden Prairie, Minnesota, is a medical technology company focused on developing and commercializing advanced thin film electrode technology for neurological applications. Founded in 2009, the company aims to enhance diagnostic and therapeutic devices for brain and spinal cord conditions using its proprietary technology. NeuroOne's innovative thin film electrodes improve continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, which are essential for diagnosing and treating neurological disorders. Their products include diagnostic devices for monitoring brain activity, therapeutic devices for spinal cord and brain stimulation, and drug delivery systems targeting affected neurological areas. The company primarily serves healthcare providers in neurology, neurosurgery, and pain management, focusing on conditions such as epilepsy, Parkinson’s disease, and chronic pain syndromes. With a commitment to research and development, NeuroOne is actively advancing its product offerings in the growing neurostimulation device market. The leadership team brings extensive experience in medical device development, driving the company's mission to provide high-definition, minimally invasive solutions for complex neurological disorders.

• Employees 17
• Founded 2009
• Annual Revenue $5758000
• Total Funding $52327451